Euractiv.com with AFP Est. 1min 30-03-2021 Medical staff member prepares shots of the Janssen (Pharmaceutical Companies of Johnson & Johnson) vaccine against Covid-19 during a vaccination operation organized by St. John's Well Child and Family Center in Los Angeles, California, USA, 25 March 2021. [EPA-EFE/ETIENNE LAURENT] Euractiv is part of the Trust Project >>> Print Email Facebook Twitter LinkedIn WhatsApp Telegram Johnson & Johnson said Monday (29 March) it would start delivering its single-shot COVID vaccine to Europe on April 19, giving the continent a boost as it struggles to speed up its vaccination drive. The pharmaceutical giant’s jab was approved by European Union regulators in mid-March, following approval of vaccines made by Pfizer-BioNTech, Moderna and AstraZeneca. The 27-nation EU has signed a firm order for 200 million J&J doses and an option for 200 million more. As well as being the first that requires just a single injection rather than two, the Johnson & Johnson vaccine is easier to store. The EMA gave the green light after saying clinical trials involving volunteers in the United States, South Africa and South American countries found the J&J jab was 67% effective at preventing people from getting COVID. Several European countries have enacted new restrictions to curb a surge of infections, as vaccination campaigns have been slower than in other countries such as the United States or Britain. Johnson and Johnson adds to COVID-19 vaccine arsenal with 66% efficacy in global trial Johnson & Johnson said on Friday (29 January) that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants which will give health officials another weapon to tackle the coronavirus. Read more with Euractiv EU parliament could approve COVID 'green' pass in June: lawmakerThe European Parliament will be ready to ratify the EU's COVID "green" pass in June, a key lawmaker said Monday (29 March), paving the way for easier travels during the key summer season.
